Tingting Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Tingting Yu has a total of 162 co-authors. Here are the top co-authors by number of shared publications:
- Shen Yue
Department of Medical Genetics, Jiangsu Key Laboratory of Xenotransplantation, Nanjing Medical University, Nanjing, China
7 shared publications - Chen Liu
Department of Medical Genetics Nanjing Medical University Nanjing China
5 shared publications - Ming Xu
Jiangsu Provincial Center for Disease Control and Prevention
5 shared publications - Steven Yan Cheng
Department of Medical Genetics, Nanjing Medical University, Nanjing, China
4 shared publications Yi Zhang
Department of Colorectal Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
4 shared publications- Baoli Zhu
School of Public Health, Nanjing Medical University, Nanjing 211166, China
3 shared publications
Latest Publications
- Open Access
- 8 March 2026
- Published by Wiley in Clinical and Translational Medicine
- Vol. 16 (3) , e70635
CMA‐mediated USP9X degradation promotes SHH medulloblastoma progression by facilitating SUFU ubiquitination
Background: Medulloblastoma (MB) represents the most prevalent malignant paediatric brain tumour, characterised by the sonic Hedgehog molecular subtype (SHH‐MB), which is driven by aberrant activation of the SHH signalling cascade. Suppressor of fused (SUFU), a core member of SHH signal transduction, functions as a tumour suppressor by inhibiting the activity of transcription factors glioma‐associated oncogene homologue (GLI)‐triggered SHH signalling pathway. While ubiquitin‐mediated proteasomal degradation of SUFU has been shown to modulate SHH signalling, the regulatory factors involved in SUFU deubiquitination and their specific roles in MB pathogenesis remain largely undefined. Methods: Mass spectrometry and co‐immunoprecipitation were employed to identify the interaction between USP9X and SUFU. Clinical correlation analyses were conducted using MB tissue microarrays and publicly available datasets. Ubiquitination assays, functional cell‐based experiments, and orthotopic xenograft models were performed to evaluate the biological role of USP9X in SHH‐MB. Chaperone‐mediated autophagy (CMA) inhibitors were utilised to investigate their regulatory effects on USP9X expression and SHH‐MB progression. Results: Mass spectrometry identified the deubiquitinase ubiquitin‐specific protease 9X (USP9X) as a previously unrecognised SUFU‐binding partner. Notably, USP9X and SUFU exhibit a positive correlation in a MB tissue array, with both exhibiting low expression levels that are associated with adverse prognostic outcomes. Loss of USP9X in SHH‐MB enhances cell proliferation in vitro as well as orthotopic MB xenograft tumourgenicity in vivo. Mechanically, USP9X deubiquitinates and stabilises SUFU, thereby negatively regulating SHH signal transduction. Interestingly, SHH signalling promotes SUFU ubiquitination through CMA‐dependent degradation of USP9X protein levels, facilitating pathway activation. Combined inhibition of CMA and SHH pathway had a synergically therapeutic effect on SHH‐MB. Conclusions: These results establish CMA and USP9X as pivotal regulators of SHH medulloblastoma MB progression, emphasising their potential as novel therapeutic targets for medulloblastoma, and combinatorial inhibition of CMA and Smoothened (SMO) may provide a strategy to overcome intrinsic or acquired resistance to SMO monotherapy in SHH‐MB. Key points: USP9X suppresses SHH medulloblastoma progression by deubiquitinating SUFU. SHH promotes USP9X degradation through the CMA pathway. Combined inhibition of CMA and SHH pathway had a synergically therapeutic effect on SHH Medulloblastoma.
- 8 March 2026
- Published by Wiley in Clinical and Translational Medicine
- Vol. 16 (3) , e70635
Open AccessCMA‐mediated USP9X degradation promotes SHH medulloblastoma progression by facilitating SUFU ubiquitination
Background: Medulloblastoma (MB) represents the most prevalent malignant paediatric brain tumour, characterised by the sonic Hedgehog molecular subtype (SHH‐MB), which is driven by aberrant activation of the SHH signalling cascade. Suppressor of fused (SUFU), a core member of SHH signal transduction, functions as a tumour suppressor by inhibiting the activity of transcription factors glioma‐associated oncogene homologue (GLI)‐triggered SHH signalling pathway. While ubiquitin‐mediated proteasomal degradation of SUFU has been shown to modulate SHH signalling, the regulatory factors involved in SUFU deubiquitination and their specific roles in MB pathogenesis remain largely undefined. Methods: Mass spectrometry and co‐immunoprecipitation were employed to identify the interaction between USP9X and SUFU. Clinical correlation analyses were conducted using MB tissue microarrays and publicly available datasets. Ubiquitination assays, functional cell‐based experiments, and orthotopic xenograft models were performed to evaluate the biological role of USP9X in SHH‐MB. Chaperone‐mediated autophagy (CMA) inhibitors were utilised to investigate their regulatory effects on USP9X expression and SHH‐MB progression. Results: Mass spectrometry identified the deubiquitinase ubiquitin‐specific protease 9X (USP9X) as a previously unrecognised SUFU‐binding partner. Notably, USP9X and SUFU exhibit a positive correlation in a MB tissue array, with both exhibiting low expression levels that are associated with adverse prognostic outcomes. Loss of USP9X in SHH‐MB enhances cell proliferation in vitro as well as orthotopic MB xenograft tumourgenicity in vivo. Mechanically, USP9X deubiquitinates and stabilises SUFU, thereby negatively regulating SHH signal transduction. Interestingly, SHH signalling promotes SUFU ubiquitination through CMA‐dependent degradation of USP9X protein levels, facilitating pathway activation. Combined inhibition of CMA and SHH pathway had a synergically therapeutic effect on SHH‐MB. Conclusions: These results establish CMA and USP9X as pivotal regulators of SHH medulloblastoma MB progression, emphasising their potential as novel therapeutic targets for medulloblastoma, and combinatorial inhibition of CMA and Smoothened (SMO) may provide a strategy to overcome intrinsic or acquired resistance to SMO monotherapy in SHH‐MB. Key points: USP9X suppresses SHH medulloblastoma progression by deubiquitinating SUFU. SHH promotes USP9X degradation through the CMA pathway. Combined inhibition of CMA and SHH pathway had a synergically therapeutic effect on SHH Medulloblastoma.
- Open Access
- 14 February 2026
- Published by Oxford University Press (OUP) in National Science Review
- Vol. 13 (7)
A novel biomacromolecule-predominated hybrid unit: from design, characterization to application
Current biomaterial designs struggle with complex clinical and life science demands as single-function approaches are increasingly inadequate, necessitating the systematic integration of four core elements: biosafety, physiological compatibility, biomechanical matching, and biocatalytic function across hierarchical levels. This study addresses this challenge by introducing a novel strategy using natural biomacromolecules to construct microscopic organic-inorganic hybrid units. A comprehensive characterization paradigm employing synchrotron SAXS, IR-AFM and high-resolution TEM was established to reveal emergent hybrid properties. Systematic characterization results demonstrate that the physicochemical properties of these hybrid units more closely resemble polymers than traditional nanomaterials. We introduced the classical polymer blob model to reveal the effects of the hybridization process on the rigidity/flexibility of the polymer chains. Combined characterization results confirmed that the hybrid units possess stable interfaces, bioinspired crosslinking, synergistic high enzyme-like activity with low toxicity, and broad pH tolerance. Multifunctional nanohybrid hydrogel fabricated with these hybrid units significantly enhances mammalian cell synthesis of high-quality PD-L1 protein with efficiency improved by nearly an order of magnitude and effectively protects skin organoids from damage caused by exogenous ROS. Integrated multi-omics analysis demonstrates the hydrogel modulates cell–cell/matrix interactions via mechano-bioinspiration, boosts endoplasmic reticulum protein processing, and ameliorates hypoxia to enhance mitochondrial respiration (without active oxygen supply), achieving systematic integration of biocompatibility, biomechanics, biocatalysis and physiological environment compatibility. The study also demonstrates the potential of hybrid units in applications such as hydrogel-derived optical fiber fabrication, 3D bio-printing and in vitro advanced cell culture models.
- 14 February 2026
- Published by Oxford University Press (OUP) in National Science Review
- Vol. 13 (7)
Open AccessA novel biomacromolecule-predominated hybrid unit: from design, characterization to application
Current biomaterial designs struggle with complex clinical and life science demands as single-function approaches are increasingly inadequate, necessitating the systematic integration of four core elements: biosafety, physiological compatibility, biomechanical matching, and biocatalytic function across hierarchical levels. This study addresses this challenge by introducing a novel strategy using natural biomacromolecules to construct microscopic organic-inorganic hybrid units. A comprehensive characterization paradigm employing synchrotron SAXS, IR-AFM and high-resolution TEM was established to reveal emergent hybrid properties. Systematic characterization results demonstrate that the physicochemical properties of these hybrid units more closely resemble polymers than traditional nanomaterials. We introduced the classical polymer blob model to reveal the effects of the hybridization process on the rigidity/flexibility of the polymer chains. Combined characterization results confirmed that the hybrid units possess stable interfaces, bioinspired crosslinking, synergistic high enzyme-like activity with low toxicity, and broad pH tolerance. Multifunctional nanohybrid hydrogel fabricated with these hybrid units significantly enhances mammalian cell synthesis of high-quality PD-L1 protein with efficiency improved by nearly an order of magnitude and effectively protects skin organoids from damage caused by exogenous ROS. Integrated multi-omics analysis demonstrates the hydrogel modulates cell–cell/matrix interactions via mechano-bioinspiration, boosts endoplasmic reticulum protein processing, and ameliorates hypoxia to enhance mitochondrial respiration (without active oxygen supply), achieving systematic integration of biocompatibility, biomechanics, biocatalysis and physiological environment compatibility. The study also demonstrates the potential of hybrid units in applications such as hydrogel-derived optical fiber fabrication, 3D bio-printing and in vitro advanced cell culture models.
- Open Access
- 1 January 2026
- Published by Journal of Biomedical Research in Journal of Biomedical Research
- Vol. 40 (3) , 228-19
GPC6 facilitates progression of SHH-subgroup medulloblastoma by enhancing Hedgehog secretion and signaling responses
Medulloblastoma (MB) is the most common malignant tumor of the cerebellum in children. The SHH subgroup of MB (SHH-MB) is driven by aberrant activation of the Sonic Hedgehog (SHH) pathway; however, mutations in genes related to this pathway are relatively rare, posing challenges for therapeutic development. Glypican-6 (GPC6), a heparan sulfate proteoglycan, is highly expressed in SHH-MB. In this study, we demonstrate the synchronous expression of GPC6 with GLI1 in both the developing cerebellum and medulloblastoma. GPC6 promoted the cell proliferation, migration, and invasion in SHH-MB cell lines (DAOY and ONS-76). Consistently, GPC6 enhanced SHH pathway activity by upregulating GLI1 expression, supported ciliogenesis that is essential for signal transduction, and facilitated the secretion of SHH ligands via extracellular vesicles. These findings establish GPC6 as a critical regulator of SHH-MB progression and highlight its potential as a therapeutic target.
- 1 January 2026
- Published by Journal of Biomedical Research in Journal of Biomedical Research
- Vol. 40 (3) , 228-19
Open AccessGPC6 facilitates progression of SHH-subgroup medulloblastoma by enhancing Hedgehog secretion and signaling responses
Medulloblastoma (MB) is the most common malignant tumor of the cerebellum in children. The SHH subgroup of MB (SHH-MB) is driven by aberrant activation of the Sonic Hedgehog (SHH) pathway; however, mutations in genes related to this pathway are relatively rare, posing challenges for therapeutic development. Glypican-6 (GPC6), a heparan sulfate proteoglycan, is highly expressed in SHH-MB. In this study, we demonstrate the synchronous expression of GPC6 with GLI1 in both the developing cerebellum and medulloblastoma. GPC6 promoted the cell proliferation, migration, and invasion in SHH-MB cell lines (DAOY and ONS-76). Consistently, GPC6 enhanced SHH pathway activity by upregulating GLI1 expression, supported ciliogenesis that is essential for signal transduction, and facilitated the secretion of SHH ligands via extracellular vesicles. These findings establish GPC6 as a critical regulator of SHH-MB progression and highlight its potential as a therapeutic target.
- Open Access
- 10 April 2025
- Published by Portland Press Ltd. in Clinical Science
- Vol. 139 (07) , 389-410
Osteoclast-derived exosomal miR-30a-3p promotes lead exposure-induced osteoporosis by triggering osteoblastic pyroptosis
High lead (Pb) burden in humans disrupts bone homeostasis and can induce osteoporosis. Here, we report that osteoclast-derived exosomes (OC-Exos) were enriched in the plasma of patients with low bone mineral density and Pb exposure. Osteoclasts (OCs) secrete microRNA-enriched exosomes, through which miR-30a-3p is transferred to osteoblasts (OBs) to induce pyroptosis, leading to the aggravation of bone loss. Mechanistically, OC-Exo-packaged miR-30a-3p triggered pyroptosis in OBs by stimulating the NLRP3 inflammasome, activating the caspase-1 pathway, and up-regulating the expression of IL-1 and IL-18. Depletion of miR-30a-3p abolished the effects of OC-Exo and alleviated the symptoms of Pb-induced osteoporosis. Collectively, our results suggest that miR-30a-3p is highly expressed in exosomes derived from OCs and mediates OB pyroptosis, inhibiting bone formation through cellular communication in Pb-induced osteoporosis. Therefore, OC-Exo-packaged miR-30a-3p may be a novel risk factor for Pb-induced osteoporosis and holds prognostic value in evaluating bone formation.
- 10 April 2025
- Published by Portland Press Ltd. in Clinical Science
- Vol. 139 (07) , 389-410
Open AccessOsteoclast-derived exosomal miR-30a-3p promotes lead exposure-induced osteoporosis by triggering osteoblastic pyroptosis
High lead (Pb) burden in humans disrupts bone homeostasis and can induce osteoporosis. Here, we report that osteoclast-derived exosomes (OC-Exos) were enriched in the plasma of patients with low bone mineral density and Pb exposure. Osteoclasts (OCs) secrete microRNA-enriched exosomes, through which miR-30a-3p is transferred to osteoblasts (OBs) to induce pyroptosis, leading to the aggravation of bone loss. Mechanistically, OC-Exo-packaged miR-30a-3p triggered pyroptosis in OBs by stimulating the NLRP3 inflammasome, activating the caspase-1 pathway, and up-regulating the expression of IL-1 and IL-18. Depletion of miR-30a-3p abolished the effects of OC-Exo and alleviated the symptoms of Pb-induced osteoporosis. Collectively, our results suggest that miR-30a-3p is highly expressed in exosomes derived from OCs and mediates OB pyroptosis, inhibiting bone formation through cellular communication in Pb-induced osteoporosis. Therefore, OC-Exo-packaged miR-30a-3p may be a novel risk factor for Pb-induced osteoporosis and holds prognostic value in evaluating bone formation.
- Open Access
- 15 February 2024
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (6)
Increasing Sufu gene dosage reveals its unorthodox role in promoting polydactyly and medulloblastoma tumorigenesis
Suppressor of fused (SUFU) is widely regarded as a key negative regulator of the sonic hedgehog (SHH) morphogenic pathway and a known tumor suppressor of medulloblastoma (MB). However, we report here that SUFU expression was markedly increased in 75% of specimens compiled in a tissue array comprising 49 unstratified MBs. The SUFU and GLI1 expression levels in this MB array showed strong positive correlation, which was also identified in a large public data set containing 736 MBs. We further report that increasing Sufu gene dosage in mice caused preaxial polydactyly, which was associated with the expansion of the Gli3 domain in the anterior limb bud and heightened Shh signaling responses during embryonic development. Increasing Sufu gene dosage also led to accelerated cerebellar development and, when combined with ablation of the Shh receptor encoded by Patched1 ( Ptch1 ), promoted MB tumorigenesis. These data reveal multifaceted roles of SUFU in promoting MB tumorigenesis by enhancing SHH signaling. This revelation clarifies potentially counterintuitive clinical observation of high SUFU expression in MBs and may pave way for novel strategies to reduce or reverse MB progression.
- 15 February 2024
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (6)
Open AccessIncreasing Sufu gene dosage reveals its unorthodox role in promoting polydactyly and medulloblastoma tumorigenesis
Suppressor of fused (SUFU) is widely regarded as a key negative regulator of the sonic hedgehog (SHH) morphogenic pathway and a known tumor suppressor of medulloblastoma (MB). However, we report here that SUFU expression was markedly increased in 75% of specimens compiled in a tissue array comprising 49 unstratified MBs. The SUFU and GLI1 expression levels in this MB array showed strong positive correlation, which was also identified in a large public data set containing 736 MBs. We further report that increasing Sufu gene dosage in mice caused preaxial polydactyly, which was associated with the expansion of the Gli3 domain in the anterior limb bud and heightened Shh signaling responses during embryonic development. Increasing Sufu gene dosage also led to accelerated cerebellar development and, when combined with ablation of the Shh receptor encoded by Patched1 ( Ptch1 ), promoted MB tumorigenesis. These data reveal multifaceted roles of SUFU in promoting MB tumorigenesis by enhancing SHH signaling. This revelation clarifies potentially counterintuitive clinical observation of high SUFU expression in MBs and may pave way for novel strategies to reduce or reverse MB progression.
- Open Access
- 9 August 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1109181
Molecular characteristics, clinical significance, and immune landscape of extracellular matrix remodeling-associated genes in colorectal cancer
Background: Extracellular matrix (ECM) remodeling is one of the hallmark events in cancer and has been shown to be closely related to tumor immunity. Immunotherapy has evolved as an important tool to treat various cancers and improve patient prognosis. The positive response to immunotherapy relies on the unique interaction between cancer and the tumor microenvironment (TME). However, the relationship between ECM remodeling and clinical outcomes, immune cell infiltration, and immunotherapy in colorectal cancer (CRC) remains unknown.Methods: We systematically evaluated 69 ECM remodeling-associated genes (EAGs) and comprehensively identified interactions between ECM remodeling and prognosis and the immune microenvironment in CRC patients. The EAG_score was used to quantify the subtype of ECM remodeling in patients. We then assessed their value in predicting prognosis and responding to treatment in CRC.Results: After elaborating the molecular characteristics of ECM remodeling-related genes in CRC patients, a model consisting of two ECM remodeling-related genes (MEIS2, SLC2A3) was developed for predicting the prognosis of CRC patients, Receiver Operating Characteristic (ROC) and Kaplan-Meier (K-M) analysis verified its reliable predictive ability. Furthermore, we created a highly reliable nomogram to enhance the clinical feasibility of the EAG_score. Significantly differences in TME and immune function, such as macrophages and CD8+ T cells, were observed between high- and low-risk CRC patients. In addition, drug sensitivity is also strongly related to EAG_score.Conclusion: Overall, we developed a prognostic model associated with ECM remodeling, provided meaningful clinical implications for immunotherapy, and facilitated individualized treatment for CRC patients. Further studies are needed to reveal the underlying mechanisms of ECM remodeling in CRC.
- 9 August 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1109181
Open AccessMolecular characteristics, clinical significance, and immune landscape of extracellular matrix remodeling-associated genes in colorectal cancer
Background: Extracellular matrix (ECM) remodeling is one of the hallmark events in cancer and has been shown to be closely related to tumor immunity. Immunotherapy has evolved as an important tool to treat various cancers and improve patient prognosis. The positive response to immunotherapy relies on the unique interaction between cancer and the tumor microenvironment (TME). However, the relationship between ECM remodeling and clinical outcomes, immune cell infiltration, and immunotherapy in colorectal cancer (CRC) remains unknown.Methods: We systematically evaluated 69 ECM remodeling-associated genes (EAGs) and comprehensively identified interactions between ECM remodeling and prognosis and the immune microenvironment in CRC patients. The EAG_score was used to quantify the subtype of ECM remodeling in patients. We then assessed their value in predicting prognosis and responding to treatment in CRC.Results: After elaborating the molecular characteristics of ECM remodeling-related genes in CRC patients, a model consisting of two ECM remodeling-related genes (MEIS2, SLC2A3) was developed for predicting the prognosis of CRC patients, Receiver Operating Characteristic (ROC) and Kaplan-Meier (K-M) analysis verified its reliable predictive ability. Furthermore, we created a highly reliable nomogram to enhance the clinical feasibility of the EAG_score. Significantly differences in TME and immune function, such as macrophages and CD8+ T cells, were observed between high- and low-risk CRC patients. In addition, drug sensitivity is also strongly related to EAG_score.Conclusion: Overall, we developed a prognostic model associated with ECM remodeling, provided meaningful clinical implications for immunotherapy, and facilitated individualized treatment for CRC patients. Further studies are needed to reveal the underlying mechanisms of ECM remodeling in CRC.
- Open Access
- 14 July 2023
- Published by Elsevier in Materials Today Bio
- Vol. 21, 100732
Mechano-biomimetic hydrogel 3D cell cultivation as a strategy to improve mammalian cell protein expression
- 14 July 2023
- Published by Elsevier in Materials Today Bio
- Vol. 21, 100732
Open AccessMechano-biomimetic hydrogel 3D cell cultivation as a strategy to improve mammalian cell protein expression
- Open Access
- 22 January 2023
- Published by Springer Nature in Cell & Bioscience
- Vol. 13 (1) , 1-17
AMPK attenuates SHH subgroup medulloblastoma growth and metastasis by inhibiting NF-κB activation
Background: Medulloblastoma (MB) is one of the most common malignant pediatric brain tumors. Metastasis and relapse are the leading causes of death in MB patients. The initiation of the SHH subgroup of MB (SHH-MB) is due to the aberrant activation of Sonic Hedgehog (Shh) signaling. However, the mechanisms for its metastasis are still unknown. Results: AMP-dependent protein kinase (AMPK) restrains the activation of Shh signaling pathway, thereby impeding the proliferation of SHH-MB cells. More importantly, AMPK also hinders the growth and metastasis of SHH-MB cells by regulating NF-κB signaling pathway. Furthermore, Vismodegib and TPCA-1, which block the Shh and NF-κB pathways, respectively, synergistically restrained the growth, migration, and invasion of SHH-MB cells. Conclusions: This work demonstrates that AMPK functions through two signaling pathways, SHH-GLI1 and NF-κB. AMPK-NF-κB axis is a potential target for molecular therapy of SHH-MB, and the combinational blockade of NF-κB and Shh pathways confers synergy for SHH-MB therapy.
- 22 January 2023
- Published by Springer Nature in Cell & Bioscience
- Vol. 13 (1) , 1-17
Open AccessAMPK attenuates SHH subgroup medulloblastoma growth and metastasis by inhibiting NF-κB activation
Background: Medulloblastoma (MB) is one of the most common malignant pediatric brain tumors. Metastasis and relapse are the leading causes of death in MB patients. The initiation of the SHH subgroup of MB (SHH-MB) is due to the aberrant activation of Sonic Hedgehog (Shh) signaling. However, the mechanisms for its metastasis are still unknown. Results: AMP-dependent protein kinase (AMPK) restrains the activation of Shh signaling pathway, thereby impeding the proliferation of SHH-MB cells. More importantly, AMPK also hinders the growth and metastasis of SHH-MB cells by regulating NF-κB signaling pathway. Furthermore, Vismodegib and TPCA-1, which block the Shh and NF-κB pathways, respectively, synergistically restrained the growth, migration, and invasion of SHH-MB cells. Conclusions: This work demonstrates that AMPK functions through two signaling pathways, SHH-GLI1 and NF-κB. AMPK-NF-κB axis is a potential target for molecular therapy of SHH-MB, and the combinational blockade of NF-κB and Shh pathways confers synergy for SHH-MB therapy.
- 10 January 2022
- Published by Wiley in Macromolecular Bioscience
- Vol. 22 (4) , 2100498
Self‐Organization Formation of Multicellular Spheroids Mediated by Mechanically Tunable Hydrogel Platform: Toward Revealing the Synergy of Chemo‐ and Noninvasive Photothermal Therapy against Colon Microtumor
Three-dimensional (3D) tumor cell culture offers a more tissue-recapitulating model in cancer treatment evaluation. However, conventional models based on cell-substrate adhesion deprivation are still of insufficient real tumor mimic. In this work, we proposed a novel method for inducing multicellular spheroids (MCSs) formation based on hydrogel with tunable microenvironmental properties. Colon tumor cells DLD1 cultured on hydrogel substrate with proper physical stimulation formed MCSs via self-organization. Chemotherapy based on clinical drug and far-infrared photothermal therapy were evaluated with DLD1 MCSs obtained by this method. The synergism of chemotherapy and noninvasive photothermal therapy based on graphene device was furtherly verified in our MCSs model and we believe this method hold potential in in vitro anti-tumor strategies evaluation for precision medicine. This article is protected by copyright. All rights reserved
- 10 January 2022
- Published by Wiley in Macromolecular Bioscience
- Vol. 22 (4) , 2100498
Self‐Organization Formation of Multicellular Spheroids Mediated by Mechanically Tunable Hydrogel Platform: Toward Revealing the Synergy of Chemo‐ and Noninvasive Photothermal Therapy against Colon Microtumor
Three-dimensional (3D) tumor cell culture offers a more tissue-recapitulating model in cancer treatment evaluation. However, conventional models based on cell-substrate adhesion deprivation are still of insufficient real tumor mimic. In this work, we proposed a novel method for inducing multicellular spheroids (MCSs) formation based on hydrogel with tunable microenvironmental properties. Colon tumor cells DLD1 cultured on hydrogel substrate with proper physical stimulation formed MCSs via self-organization. Chemotherapy based on clinical drug and far-infrared photothermal therapy were evaluated with DLD1 MCSs obtained by this method. The synergism of chemotherapy and noninvasive photothermal therapy based on graphene device was furtherly verified in our MCSs model and we believe this method hold potential in in vitro anti-tumor strategies evaluation for precision medicine. This article is protected by copyright. All rights reserved
- 1 January 2022
- Published by Springer Nature
- Vol. 2445, 39-50
CRISPR-Cas9 Gene Editing to Generate Isoform-Specific LAMP-2A Knockout in Human Cancer Cells
Chaperone-mediated autophagy (CMA) is a highly specific lysosomal-dependent protein degradation pathway. A critical molecular component of CMA is the lysosome-associated membrane protein (LAMP) type 2A, which is required for substrate uptake by the lysosome. Defects in the CMA pathway have been associated with various human pathologies, including malignancies, increasing the overall interest in methods to monitor this selective autophagy process. Yet isogenic LAMP-2A knockout cancer cell models are still lacking. This is likely to depend on challenges related to that human LAMP-2 gene undergoes alternative splicing of its pre-mRNA, generating three isoform variants, LAMP-2A, LAMP-2B, and LAMP-2C. However, without assessment of the impact of LAMP-2A loss of function specifically in human cells, the involvement of CMA in human pathologies, including carcinogenesis remains speculative. Here, we describe the generation of isoform-specific CRISPR-Cas9 genomic editing of LAMP-2A in human cancer cells, without affecting the other two isoforms, allowing for experimental evaluation of LAMP-2A, thus CMA in human cancer models.
- 1 January 2022
- Published by Springer Nature
- Vol. 2445, 39-50
CRISPR-Cas9 Gene Editing to Generate Isoform-Specific LAMP-2A Knockout in Human Cancer Cells
Chaperone-mediated autophagy (CMA) is a highly specific lysosomal-dependent protein degradation pathway. A critical molecular component of CMA is the lysosome-associated membrane protein (LAMP) type 2A, which is required for substrate uptake by the lysosome. Defects in the CMA pathway have been associated with various human pathologies, including malignancies, increasing the overall interest in methods to monitor this selective autophagy process. Yet isogenic LAMP-2A knockout cancer cell models are still lacking. This is likely to depend on challenges related to that human LAMP-2 gene undergoes alternative splicing of its pre-mRNA, generating three isoform variants, LAMP-2A, LAMP-2B, and LAMP-2C. However, without assessment of the impact of LAMP-2A loss of function specifically in human cells, the involvement of CMA in human pathologies, including carcinogenesis remains speculative. Here, we describe the generation of isoform-specific CRISPR-Cas9 genomic editing of LAMP-2A in human cancer cells, without affecting the other two isoforms, allowing for experimental evaluation of LAMP-2A, thus CMA in human cancer models.